Harry Boxer
The Technical Trader
The stock market indices had a very tough opening as they gapped down sharply. They rallied back sharply, made lower lows on the S&P 500, and when the Nasdaq 100 didn't do so, they held support and rallied back in a 5-wave advance, taking the indices substantially into the plus column. But in the last couple hours they backed off again finishing negatively for the day.
Net on the day, the Dow was down 40.31 at 17,678.23, about 100 off the lows and about 80 points off the high. The S&P 500 was down 4.90 at 2056.15. The Nasdaq 100 was down 14.03 at 4315.26.
Advance-declines were still 3 to 2 negative on the New York Stock Exchange, and 5 to 4 negative on Nasdaq. Up/down volume was a little less than 2 to 1 negative on New York, with total volume of 3.4 billion shares. Nasdaq traded close to 2 billion shares, and had a 11 to 9 negative volume ratio.
TheTechTrader.com board was mixed but there was a lot of red in it. Priceline.com Incorporated (PCLN) was down 12.34 to 1140.36, Google Inc. (GOOG) down 3.61 to 555.17, Amazon.com Inc. (AMZN) also down 3.61 to 367.35, Netflix, Inc. (NFLX) 3.49 to 418.26. Apple Inc. (AAPL) was up 86 cents to 124.24.
Tesla Motors, Inc. (TSLA) lost 3.90 to 190.40.
On the plus side, Cyber-Ark Software Ltd. (CYBR) climbed 2.73 to 52.87 in a strong cyber-security group today. NewLink Genetics Corporation (NLNK) bounced back from 44.25, up 1.57 to 48.93.
Checking the TheTechTrader.com percent-gain leaderboard, there were some interesting moves in the morning. Thinly traded Lime Energy Co. (LIME) gained 65 cents to 4.00, or 20%, continuing after yesterday's acquisition of EnerPath.
Conatus Pharmaceuticals Inc. (CNAT) ran to 8.46 today, before pulling back to 6.76, up 1.00, or 17 1/2%, on 13 million shares.
Diplomat Pharmacy, Inc. (DPLO) jumped to 35.00 even today, closing up 4.28 to 34.63, or 14%, on 6 million shares. Red Hat, Inc. (RHT) climbed 6.91 to 75.36, or 10%, on 10.8 million shares. Five Below, Inc. (FIVE) gained 3.33 to 35.55, or 10%, on 9.1 million shares, on earnings. Coherus Biosciences, Inc. (CHRS) popped 2.42 to 26.97.
Oils were strong today. The ProShares Ultra
Bloomberg Crude Oil (UCO) advanced 73 cents to 7.97, or 10%, on 29 million shares. Let's see what happens tomorrow. Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
EUR/USD eases to near 1.0700 ahead of German inflation data
EUR/USD is paring gains to near 1.0700 in the European session on Monday. The pair stays supported by a softer US Dollar, courtesy of the USD/JPY sell-off and a risk-friendly market environment. Germany's inflation data is next in focus.
USD/JPY recovers after testing 154.50 on likely Japanese intervention
USD/JPY is recovering ground after sliding to 154.50 on what seemed like a Japanese FX intervention. The Yen tumbled in early trades amid news that Japan's PM lost 3 key seats in the by-election. Focus shifts to the US employment data and the Fed decision later this week.
Gold price holds steady above $2,335, bulls seem reluctant amid reduced Fed rate cut bets
Gold price (XAU/USD) attracts some buyers near the $2,320 area and turns positive for the third successive day on Monday, albeit the intraday uptick lacks bullish conviction.
Ripple CTO shares take on ETHgate controversy, XRP holders await SEC opposition brief filing
Ripple loses all gains from the past seven days, trading at $0.50 early on Monday. XRP holders have their eyes peeled for the Securities and Exchange Commission filing of opposition brief to Ripple’s motion to strike expert testimony.
Week ahead: FOMC and jobs data in sight
May kicks off with the Federal Open Market Committee meeting and will be one to watch, scheduled to make the airwaves on Wednesday. It’s pretty much a sealed deal for a no-change decision at this week’s meeting.